Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | C336 | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | Probe:50uM; negative probe:50uM | |||||
| Criteria | Quantification: AfBPP Probe vs Negative Probe | |||||
| Quantitative Method |
TMT
|
|||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Peripheral blood | ||||
| Disease Model | Normal | |||||
| Model Name | Human normal cells (HEK-293T) | |||||
| Note | Negative probe:C#CCCC1(CCC(NC)=O)N=N1 | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP09256 | Putative phospholipase B-like 2 (PLBD2) | 9.6 | ||||
| LDTP16032 | Retinoid-inducible serine carboxypeptidase (SCPEP1) | 7.9 | ||||
| LDTP02539 | Lysosomal acid phosphatase (ACP2) | 6.3 | ||||
| LDTP00316 | Ribonuclease T2 (RNASET2) | 6.3 | ||||
| LDTP13358 | Leucyl-cystinyl aminopeptidase (LNPEP) | 6.1 | ||||
| LDTP02141 | Alpha-galactosidase A (GLA) | 5.7 | ||||
| LDTP01241 | Bis(monoacylglycero)phosphate synthase CLN5 (CLN5) | 5.5 | ||||
Transporter and channel
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP02071 | Amyloid-beta precursor protein (APP) | 7.7 | ||||
| LDTP17641 | Solute carrier family 35 member F2 (SLC35F2) | 6.3 | ||||
| LDTP14952 | Mpv17-like protein 2 (MPV17L2) | 6.2 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP07703 | Seizure 6-like protein 2 (SEZ6L2) | 9.3 | ||||
| LDTP05558 | Galectin-3-binding protein (LGALS3BP) | 5.7 | ||||
